113 related articles for article (PubMed ID: 3942605)
1. Transport of a fluorescent antifolate by methotrexate-sensitive and methotrexate-resistant human leukemic lymphoblasts.
Rosowsky A; Wright JE; Cucchi CA; Boeheim K; Frei E
Biochem Pharmacol; 1986 Jan; 35(2):356-60. PubMed ID: 3942605
[No Abstract] [Full Text] [Related]
2. A fluorescent derivative of methotrexate as an intracellular marker for dihydrofolate reductase in L1210 cells.
Henderson GB; Russell A; Whiteley JM
Arch Biochem Biophys; 1980 Jun; 202(1):29-34. PubMed ID: 6772112
[No Abstract] [Full Text] [Related]
3. Flow cytometric characterization of antifolate resistance in cultured mammalian cells using fluoresceinated methotrexate and daunorubicin.
Sherwood SW; Assaraf YG; Molina A; Schimke RT
Cancer Res; 1990 Aug; 50(16):4946-50. PubMed ID: 2143099
[TBL] [Abstract][Full Text] [Related]
4. Effects of methotrexate esters and other lipophilic antifolates on methotrexate-resistant human leukemic lymphoblasts.
Rosowsky A; Lazarus H; Yuan GC; Beltz WR; Mangini L; Abelson HT; Modest EJ; Frei E
Biochem Pharmacol; 1980 Feb; 29(4):648-52. PubMed ID: 6929188
[No Abstract] [Full Text] [Related]
5. Determinants of the disparate antitumor activities of (6R)-5,10-dideaza-5,6,7,8-tetrahydrofolate and methotrexate toward human lymphoblastic leukemia cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM; McGuire JJ
Biochem Pharmacol; 1993 Dec; 46(12):2185-95. PubMed ID: 7506026
[TBL] [Abstract][Full Text] [Related]
6. A fluorescent analogue of methotrexate as a probe for folate antagonist molecular receptors.
Susten SS; Kempton RJ; Black AM; Freisheim JH
Biochem Pharmacol; 1984 Jun; 33(12):1957-62. PubMed ID: 6732854
[TBL] [Abstract][Full Text] [Related]
7. Determinants of the disparate antitumor effects of (6R)5,10-dideaza-5,6,7,8- tetrahydrofolate and methotrexate toward methotrexate resistant CCRF-CEM cells, characterized by severely impaired antifolate membrane transport.
Matherly LH; Angeles SM
Adv Exp Med Biol; 1993; 338():783-6. PubMed ID: 8304229
[No Abstract] [Full Text] [Related]
8. Mechanism-based approaches to inhibition of the synthesis and degradation of folate and antifolate polyglutamates.
Kalman TI
Adv Exp Med Biol; 1993; 338():639-43. PubMed ID: 7508172
[No Abstract] [Full Text] [Related]
9. Internalization of Methotrexate Conjugates by Folate Receptor-α.
Nogueira E; Sárria MP; Azoia NG; Antunes E; Loureiro A; Guimarães D; Noro J; Rollett A; Guebitz G; Cavaco-Paulo A
Biochemistry; 2018 Dec; 57(49):6780-6786. PubMed ID: 30452231
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a novel transport system for folate compounds in wild-type and methotrexate-resistant L1210 cells.
Henderson GB; Strauss BP
Cancer Res; 1990 Mar; 50(6):1709-14. PubMed ID: 2306724
[TBL] [Abstract][Full Text] [Related]
11. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells.
Fotoohi AK; Albertioni F
Leuk Lymphoma; 2008 Mar; 49(3):410-26. PubMed ID: 18297517
[TBL] [Abstract][Full Text] [Related]
13. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro.
Kamen BA; Eibl B; Cashmore A; Bertino J
Biochem Pharmacol; 1984 May; 33(10):1697-9. PubMed ID: 6233981
[No Abstract] [Full Text] [Related]
14. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis.
Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G
Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783
[TBL] [Abstract][Full Text] [Related]
15. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells.
Sirotnak FM; Donsbach RC
Cancer Res; 1974 Feb; 34(2):371-7. PubMed ID: 4855750
[No Abstract] [Full Text] [Related]
16. Altered transport of folic acid and antifolates through the carrier mediated reduced folate transport system in a human leukemia cell line resistant to (6R) 5,10-dideazatetrahydrofolic acid (DDATHF).
Pavlovic M; Leffert JJ; Russello O; Bunni MA; Beardsley GP; Priest DG; Pizzorno G
Adv Exp Med Biol; 1993; 338():775-8. PubMed ID: 8304227
[No Abstract] [Full Text] [Related]
17. Intrinsic resistance to methotrexate of cultured mammalian cells in relation to the inhibition kinetics of their dihydrololate reductases.
Jackson RC; Hart LI; Harrap KR
Cancer Res; 1976 Jun; 36(6):1991-7. PubMed ID: 5189
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein confers methotrexate resistance in 3T6 cells with deficient carrier-mediated methotrexate uptake.
de Graaf D; Sharma RC; Mechetner EB; Schimke RT; Roninson IB
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):1238-42. PubMed ID: 8577747
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of dihydrofolate reductase, methotrexate transport, and growth of methotrexate-sensitive and -resistant L1210 leukemia cells in vitro by 5-substituted 2,4-diaminoquinazolines.
Susten SS; Hynes JB; Kumar A; Freisheim JH
Biochem Pharmacol; 1985 Jun; 34(12):2163-7. PubMed ID: 4004934
[TBL] [Abstract][Full Text] [Related]
20. Selectively weakened binding of methotrexate by human dihydrofolate reductase allows rapid ex vivo selection of mammalian cells.
Volpato JP; Mayotte N; Fossati E; Guerrero V; Sauvageau G; Pelletier JN
J Mol Recognit; 2011; 24(2):188-98. PubMed ID: 21360609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
